New Tests & Research in the Fight Against COVID-19 & Cancer: September 2020 News

In recent weeks, we’ve seen further advances in the molecular diagnostic sector’s response to the COVID-19 pandemic. Labs are scaling to meet the demand for more testing, and the FDA has provided emergency authorization for new types of tests. The sector also continues to push forward with new cancer tests that will have a significant impact on patient outcomes. COVID-19 […]

Read More

Laboratories Boost Capacity to Support Widespread Testing: August 2020 News

In our previous recap of industry news, we looked at the exciting partnerships and collaborations driving change, C-Suite and Board additions, and mergers and acquisitions. The Molecular Diagnostic Industry continues to innovate and grow, with laboratories and other industry partners working together to expedite COVID-19 testing and advance the community’s knowledge of the coronavirus. At the same time, clinical labs […]

Read More

Innovation & Growth Drive the NGS Clinical Diagnostic Industry: June 2020 News

Next-generation sequencing (NGS) clinical diagnostic labs are playing a key role in efforts to assess the spread of the COVID-19 virus and to develop a vaccine and therapeutics. At the same time, they continue to collaborate and innovate, develop breakthroughs, and advance patient outcomes. In this post, we look at a few standout examples. Exciting Partnerships & Collaborations Driving Change […]

Read More